Division of Hematology and Oncology Archive — Page 1 of 16

October 13, 2026

Cancer’s Andreana Holowatyj honored by Chamber of Commerce

Holowatyj leads a renowned biomedical research program committed to tackling the rising tide of early-onset cancers among adults under age 50.

September 25, 2026

Study identifies factors driving effectiveness of off-the-shelf CAR-T therapy

The team’s findings could lead to new strategies which improve efficacy of these treatments and expand lifesaving options for cancer patients.

(iStock)
September 14, 2026

How ‘mismatched donors’ are opening new doors for blood cancer patients

The ACCESS trial allowed mismatched, unrelated donors for blood cancer patients who didn’t have a perfect match for a stem cell transplant; the trial enrolled a more varied population of patients.

September 2, 2026

Decoding the ancestry gap in diagnosing and treating acute myeloid leukemia

The disease is driven by complex combinations of multiple genetic mutations rather than a single defect.

(iStock)
July 22, 2026

Discover what’s next in cancer cell therapy at Aug. 29 symposium

Sessions will focus on current advances in stem cell transplantation and cancer cell therapy, and emerging applications of these novel therapies in hematologic disorders and solid tumors.

June 23, 2026

Vanderbilt Health lands three of 35 Susan G. Komen research grants

Komen is the largest nonprofit funder of breast cancer research outside of the U.S. government, having invested more than $1.1 billion in research since its founding.